Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1955 1
1962 1
1965 1
1969 3
1975 3
1977 2
1979 3
1980 5
1981 1
1982 5
1983 3
1984 1
1985 1
1986 3
1987 2
1990 2
1997 1
1998 1
2000 2
2001 4
2002 1
2003 2
2004 4
2006 5
2007 8
2008 9
2009 17
2010 25
2011 24
2012 22
2013 27
2014 22
2015 30
2016 37
2017 26
2018 47
2019 29
2020 45
2021 37
2022 27
2023 36
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Results by year

Filters applied: . Clear all
Page 1
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality.
Sing CW, Lin TC, Bartholomew S, Bell JS, Bennett C, Beyene K, Bosco-Levy P, Bradbury BD, Chan AHY, Chandran M, Cooper C, de Ridder M, Doyon CY, Droz-Perroteau C, Ganesan G, Hartikainen S, Ilomaki J, Jeong HE, Kiel DP, Kubota K, Lai EC, Lange JL, Lewiecki EM, Lin J, Liu J, Maskell J, de Abreu MM, O'Kelly J, Ooba N, Pedersen AB, Prats-Uribe A, Prieto-Alhambra D, Qin SX, Shin JY, Sørensen HT, Tan KB, Thomas T, Tolppanen AM, Verhamme KMC, Wang GH, Watcharathanakij S, Wood SJ, Cheung CL, Wong ICK. Sing CW, et al. Among authors: bell js. J Bone Miner Res. 2023 Aug;38(8):1064-1075. doi: 10.1002/jbmr.4821. Epub 2023 May 29. J Bone Miner Res. 2023. PMID: 37118993 Free article.
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.
Jhaveri K, Eli LD, Wildiers H, Hurvitz SA, Guerrero-Zotano A, Unni N, Brufsky A, Park H, Waisman J, Yang ES, Spanggaard I, Reid S, Burkard ME, Vinayak S, Prat A, Arnedos M, Bidard FC, Loi S, Crown J, Bhave M, Piha-Paul SA, Suga JM, Chia S, Saura C, Garcia-Saenz JÁ, Gambardella V, de Miguel MJ, Gal-Yam EN, Rapael A, Stemmer SM, Ma C, Hanker AB, Ye D, Goldman JW, Bose R, Peterson L, Bell JSK, Frazier A, DiPrimeo D, Wong A, Arteaga CL, Solit DB. Jhaveri K, et al. Among authors: bell jsk. Ann Oncol. 2023 Oct;34(10):885-898. doi: 10.1016/j.annonc.2023.08.003. Epub 2023 Aug 18. Ann Oncol. 2023. PMID: 37597578 Free article. Clinical Trial.
Deprescribing proton pump inhibitors.
Turner JP, Thompson W, Reeve E, Bell JS. Turner JP, et al. Among authors: bell js. Aust J Gen Pract. 2022 Nov;51(11):845-848. doi: 10.31128/AJGP-07-22-6497. Aust J Gen Pract. 2022. PMID: 36310001 Free article.
Accounting for frailty when treating chronic diseases.
Onder G, Vetrano DL, Marengoni A, Bell JS, Johnell K, Palmer K; Optimising Pharmacotherapy through Pharmacoepidemiology Network (OPPEN). Onder G, et al. Among authors: bell js. Eur J Intern Med. 2018 Oct;56:49-52. doi: 10.1016/j.ejim.2018.02.021. Epub 2018 Mar 9. Eur J Intern Med. 2018. PMID: 29526651 Review.
Is my older cancer patient on too many medications?
Turner JP, Shakib S, Bell JS. Turner JP, et al. Among authors: bell js. J Geriatr Oncol. 2017 Mar;8(2):77-81. doi: 10.1016/j.jgo.2016.10.003. Epub 2016 Nov 11. J Geriatr Oncol. 2017. PMID: 27840102 Review.
Strategies to simplify complex medication regimens.
Bell JS, McInerney B, Chen EY, Bergen PJ, Reynolds L, Sluggett JK. Bell JS, et al. Aust J Gen Pract. 2021 Jan-Feb;50(1-2):43-48. doi: 10.31128/AJGP-04-20-5322. Aust J Gen Pract. 2021. PMID: 33543163 Free article.
447 results